rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
37	Hypertriglyceridemia	C0020557	8	119	1.51151313688e-11	3.510436432637571e-05	APOA2,APOA4,GPIHBP1,APOC3,APOC2,APOA1,APOE,LPL
38	Abnormality of lipid metabolism	C4025650	6	172	1.70591318849e-11	3.6053130929791276e-05	GPIHBP1,APOC3,APOC2,APOA1,APOE,LPL
42	Hyperlipidemia, combined, 1	C0020473	9	293	3.13278292197e-11	3.984819734345351e-05	APOA2,APOA4,GPIHBP1,APOC3,APOC2,APOA1,APOE,APOC1,LPL
47	Hypertriglyceridemia result	C1522137	7	44	3.79564157882e-11	4.459203036053131e-05	APOA2,APOA4,APOC3,APOC2,APOA1,APOE,LPL
48	Familial type 3 hyperlipoproteinemia	C0020479	6	34	3.87427867565e-11	4.554079696394687e-05	APOC3,APOC2,APOA1,APOE,APOC1,LPL
49	Hyperlipidemia, familial combined	C0020474	6	95	4.33590940929e-11	4.648956356736243e-05	APOA2,APOA4,APOC3,APOA1,APOE,LPL
50	Abnormality of the level of lipoprotein cholesterol	C4023615	5	33	4.50273152097e-11	4.743833017077799e-05	GPIHBP1,APOC3,APOA1,APOE,LPL
51	Metabolic Syndrome X	C0524620	9	638	4.7825521321e-11	4.838709677419355e-05	APOA2,APOA4,TOMM40,APOC3,APOC2,APOA1,APOE,APOC1,LPL
52	Insulin resistance syndrome	C3714619	5	48	5.1557424996e-11	4.933586337760911e-05	APOA2,APOA4,APOC2,APOC1,LPL
53	Abnormality of cholesterol metabolism	C4025656	5	59	5.26664267753e-11	5.028462998102467e-05	GPIHBP1,APOC3,APOA1,APOE,LPL
54	Cholecystolithiasis	C0947622	6	86	5.6737392562e-11	5.123339658444023e-05	APOA4,APOC3,APOA1,APOE,APOC1,LPL
55	Hyperlipoproteinemia	C0020476	7	43	5.67982327837e-11	5.218216318785579e-05	APOA2,GPIHBP1,APOC3,APOC2,APOA1,APOE,LPL
57	body mass	C0518010	5	94	6.70159483462e-11	5.407969639468691e-05	APOA2,APOA4,APOC3,APOA1,APOE
58	Hepatitis C	C0019196	8	721	6.71475097747e-11	5.502846299810247e-05	APOA2,TOMM40,APOC3,APOC2,APOA1,APOE,APOC1,LPL
59	Familial hypercholesterolemia	C0020445	7	182	6.84179379817e-11	5.5977229601518024e-05	APOA2,APOA4,APOC3,APOC2,APOA1,APOE,LPL
62	Hypercholesterolemia, autosomal dominant, type B	C0020443	6	212	9.15251208156e-11	5.882352941176471e-05	APOA2,APOA4,APOC3,APOA1,APOE,LPL
65	Atherosclerosis	C0004153	9	1271	2.5700164219e-10	6.166982922201139e-05	APOA2,APOA4,GPIHBP1,APOC3,APOC2,APOA1,APOE,APOC1,LPL
66	Disorders of lipoid metabolism	C0154251	4	65	3.09764436324e-10	6.261859582542695e-05	APOA2,APOC3,APOE,LPL
68	Cholelithiasis	C0008350	5	171	3.88120202643e-10	6.451612903225807e-05	APOA4,APOC3,APOA1,APOE,APOC1
69	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	C0740394	4	69	4.00039001924e-10	6.546489563567363e-05	APOA4,APOC3,APOA1,APOE
70	 Cerebrovascular disease, occlusive (3)	C0007820	4	73	5.19908116559e-10	6.641366223908918e-05	APOA4,APOC3,APOA1,APOE
72	Alzheimer Disease, Late Onset	C0494463	4	77	6.70963062888e-10	6.83111954459203e-05	TOMM40,APOC2,APOE,APOC1
76	Inflammation	C0021368	7	647	8.68705329893e-10	7.210626185958255e-05	APOA2,APOA4,APOC3,APOA1,APOE,APOC1,LPL
77	Drug Eruptions	C0011609	3	25	1.04813602242e-09	7.305502846299811e-05	APOC3,APOC2,APOA1
78	Cardiovascular Diseases	C0007222	8	1029	1.08766728957e-09	7.400379506641367e-05	APOA4,TOMM40,APOC3,APOC2,APOA1,APOE,APOC1,LPL
79	Arteriosclerosis	C0003850	8	1059	1.37844247128e-09	7.495256166982923e-05	APOA2,APOA4,GPIHBP1,APOC3,APOC2,APOA1,APOE,LPL
81	Old myocardial infarction	C0155668	3	29	1.82691450856e-09	7.685009487666033e-05	APOA4,APOA1,APOE
82	Steatohepatitis	C2711227	5	222	1.89180904275e-09	7.77988614800759e-05	APOC3,APOA1,APOE,APOC1,LPL
83	Hepatic steatosis	C0015695	6	427	2.01237604358e-09	7.874762808349146e-05	GPIHBP1,APOC3,APOA1,APOE,APOC1,LPL
84	Dyslipidemias	C0242339	5	228	2.23830620705e-09	7.969639468690702e-05	APOC3,APOC2,APOA1,APOE,LPL
85	Systemic arterial pressure	C1272641	6	442	2.54820486933e-09	8.064516129032258e-05	APOA2,APOA4,APOC3,APOA1,APOE,LPL
86	Coronary heart disease 7	C0010054	7	754	2.94780422294e-09	8.159392789373814e-05	APOA2,APOA4,APOC3,APOA1,APOE,APOC1,LPL
91	Carotid Atherosclerosis	C0577631	4	111	4.13388545617e-09	8.633776091081593e-05	APOA4,APOC3,APOA1,APOE
92	Abnormality of pancreas physiology	C4023048	4	115	4.86635587382e-09	8.728652751423149e-05	GPIHBP1,APOC2,APOE,LPL
95	Splenomegaly	C0038002	5	285	8.35809621513e-09	9.013282732447818e-05	GPIHBP1,APOC2,APOA1,APOE,LPL
96	Obesity, Visceral	C2936179	3	42	8.43804137673e-09	9.108159392789374e-05	APOA2,APOC3,LPL
98	Abdominal obesity	C0311277	4	134	1.05056165989e-08	9.297912713472486e-05	APOC3,APOA1,APOE,LPL
99	Coronary Artery Disease	C1956346	8	1366	1.28090740237e-08	9.392789373814042e-05	APOA2,APOA4,APOC3,APOC2,APOA1,APOE,APOC1,LPL
101	Diabetes mellitus type 2	C0011860	9	1972	1.51059910136e-08	9.582542694497154e-05	APOA2,APOA4,TOMM40,APOC3,APOC2,APOA1,APOE,APOC1,LPL
103	Insulin Resistance	C0021655	5	332	2.06436727712e-08	9.772296015180265e-05	APOA2,APOC3,APOA1,APOE,LPL
104	Abnormality of the spleen	C4025749	5	347	2.68312285723e-08	9.867172675521823e-05	GPIHBP1,APOC2,APOA1,APOE,LPL
105	Carotid Stenosis	C0007282	4	162	2.72304150339e-08	9.962049335863378e-05	APOA1,APOE,APOC1,LPL
106	Myocardial Infarction	C0027051	7	1019	3.07818532885e-08	0.00010056925996204934	APOA2,APOA4,APOC3,APOA1,APOE,APOC1,LPL
109	Blood pressure finding	C1271104	5	386	5.04556234571e-08	0.000103415559772296	APOA2,APOA4,APOC3,APOA1,APOE
110	Mental deterioration	C0234985	4	192	6.36479463578e-08	0.00010436432637571158	TOMM40,GPIHBP1,APOE,APOC1
111	Fetal Membranes, Premature Rupture	C0015943	4	194	6.70615142306e-08	0.00010531309297912714	APOC3,APOA1,APOE,LPL
112	Chorioamnionitis	C0008495	4	195	6.87557111245e-08	0.0001062618595825427	APOC3,APOA1,APOE,LPL
113	Premature Obstetric Labor	C0022876	4	203	8.40220367726e-08	0.00010721062618595825	APOC3,APOA1,APOE,LPL
114	Age-related macular degeneration 2	C0242383	5	423	8.66486784545e-08	0.00010815939278937381	TOMM40,APOC3,APOE,APOC1,LPL
115	Abnormality of the lymphatic system	C4021976	5	426	9.03554883136e-08	0.00010910815939278939	GPIHBP1,APOC2,APOA1,APOE,LPL
117	Brain Infarction	C0751955	3	77	1.0067627032e-07	0.0001110056925996205	APOA1,APOE,LPL
118	Abnormality of the pancreas	C4025751	4	212	1.04302319781e-07	0.00011195445920303605	GPIHBP1,APOC2,APOE,LPL
120	Cognitive Dysfunction	C0338656	6	769	1.11965638872e-07	0.00011385199240986717	TOMM40,GPIHBP1,APOA1,APOE,APOC1,LPL
121	Overweight	C0497406	4	217	1.17056953575e-07	0.00011480075901328274	APOC3,APOA1,APOE,LPL
122	Restenosis	C0333186	4	220	1.25347552005e-07	0.0001157495256166983	APOA4,APOC3,APOE,LPL
124	Plaque, Atherosclerotic	C0011389	4	226	1.43277114617e-07	0.00011764705882352942	APOA4,APOA1,APOE,LPL
125	Visceromegaly	C0042782	5	461	1.43917229134e-07	0.00011859582542694497	GPIHBP1,APOC2,APOA1,APOE,LPL
129	Diabetic Angiopathies	C0011875	3	88	1.72821911226e-07	0.00012239089184060722	APOA4,APOE,LPL
130	Dementia	C0497327	5	477	1.75917736156e-07	0.00012333965844402278	GPIHBP1,APOA1,APOE,APOC1,LPL
133	Acute myocardial ischemia	C0151744	5	484	1.9172017629e-07	0.00012618595825426946	APOA4,APOC3,APOA1,APOE,LPL
134	Venous Thromboembolism	C1861172	4	240	1.93156014627e-07	0.00012713472485768502	APOA4,APOC3,APOE,LPL
137	Abnormality of abdomen morphology	C4020869	5	505	2.46014635885e-07	0.0001299810246679317	GPIHBP1,APOC2,APOA1,APOE,LPL
138	Memory impairment	C0233794	4	255	2.60833293741e-07	0.00013092979127134725	GPIHBP1,APOA1,APOE,APOC1
139	Nephrotic syndrome, type 5, with or without ocular abnormalities	C0027726	4	263	3.0402051443e-07	0.0001318785578747628	APOA4,APOA1,APOE,LPL
158	Acute pancreatitis	C0001339	3	103	3.25869486062e-07	0.00014990512333965846	GPIHBP1,APOE,LPL
159	Localized skin lesion	C0850826	5	530	3.26729248212e-07	0.00015085388994307401	GPIHBP1,APOC2,APOA1,APOE,LPL
161	Pancreatitis	C0030305	4	277	3.92979861763e-07	0.0001527514231499051	GPIHBP1,APOC2,APOE,LPL
162	Diabetes Mellitus, Type 1	C0011849	8	2081	4.84859703276e-07	0.00015370018975332066	APOA2,APOA4,TOMM40,GPIHBP1,APOC3,APOA1,APOE,LPL
163	Abnormal inflammatory response	C4022805	5	581	5.59617060136e-07	0.00015464895635673625	GPIHBP1,APOC2,APOA1,APOE,LPL
164	Increased inflammatory response	C4022803	5	581	5.59617060136e-07	0.0001555977229601518	GPIHBP1,APOC2,APOA1,APOE,LPL
165	Aortic atherosclerosis	C0155733	2	29	5.89062977951e-07	0.00015654648956356737	APOE,LPL
166	Steatorrhea	C0038238	2	29	5.89062977951e-07	0.00015749525616698293	APOC2,LPL
167	Dementia familial British	C0011265	4	302	6.02187104071e-07	0.00015844402277039848	APOA1,APOE,APOC1,LPL
168	Glucose intolerance	C0271650	4	304	6.22100552183e-07	0.00015939278937381404	APOC2,APOA1,APOE,LPL
169	Gallbladder Diseases	C0016977	2	31	7.24093546678e-07	0.0001603415559772296	APOA1,APOE
170	Acute Coronary Syndrome	C0948089	4	320	8.01114588778e-07	0.00016129032258064516	APOC3,APOA1,APOE,LPL
171	Amyloidosis	C0002726	3	129	8.04237585195e-07	0.00016223908918406072	APOA2,APOA1,APOE
172	Cholestasis, benign recurrent intrahepatic 1	C0008370	4	328	9.04739422714e-07	0.00016318785578747628	GPIHBP1,APOC3,APOA1,LPL
173	Pulmonary Embolism	C0034065	3	133	9.08700711122e-07	0.00016413662239089184	APOA4,GPIHBP1,APOE
191	Mild cognitive impairment	C1270972	3	141	1.14772605841e-06	0.00018121442125237192	TOMM40,APOC2,APOE
192	Hyperthyroidism	C0020550	3	141	1.14772605841e-06	0.00018216318785578748	APOA2,APOC3,APOA1
193	Hyperinsulinemia	C0020459	4	355	1.33485687415e-06	0.00018311195445920304	APOA2,APOE,APOC1,LPL
194	Pregnancy associated hypertension	C0852036	2	38	1.35563186621e-06	0.0001840607210626186	APOC3,LPL
195	Alzheimer Disease	C0002395	7	1699	1.56140640095e-06	0.00018500948766603416	TOMM40,APOC3,APOC2,APOA1,APOE,APOC1,LPL
196	Congenital Myotonic Dystrophy	C0410226	3	153	1.5900208914e-06	0.00018595825426944972	APOC2,APOE,APOC1
197	Preeclampsia/eclampsia 1	C0032914	4	371	1.65734394975e-06	0.0001869070208728653	APOC3,APOA1,APOE,LPL
198	Premature Birth	C0151526	4	376	1.76984736733e-06	0.00018785578747628084	APOC3,APOA1,APOE,LPL
199	Abnormality of the retinal vasculature	C4024753	3	159	1.85348720805e-06	0.0001888045540796964	GPIHBP1,APOC2,LPL
200	Steinert myotonic dystrophy syndrome	C0027126	3	160	1.90032941549e-06	0.00018975332068311195	APOC2,APOE,APOC1
210	Hyperlipoproteinemia Type IIa	C0745103	2	43	1.97967781612e-06	0.00019924098671726757	APOA2,APOE
211	Abnormality of the liver	C4021780	5	727	2.0644812696e-06	0.00020018975332068313	GPIHBP1,APOC2,APOA1,APOE,LPL
212	Hepatomegaly	C0019209	4	397	2.30969907633e-06	0.00020113851992409869	GPIHBP1,APOC2,APOA1,APOE
213	Ischemic stroke	C0948008	4	401	2.42582964249e-06	0.00020208728652751424	APOC3,APOA1,APOE,LPL
214	Kidney Diseases	C0022658	5	755	2.56966516388e-06	0.0002030360531309298	APOA4,APOC3,APOA1,APOE,LPL
215	Vascular Diseases	C0042373	4	410	2.70401154834e-06	0.00020398481973434536	APOC3,APOA1,APOE,LPL
216	Coronary Restenosis	C0948480	2	49	2.94920839061e-06	0.00020493358633776092	APOE,LPL
217	Cerebral Amyloid Angiopathy	C0085220	2	50	3.13634924276e-06	0.00020588235294117645	APOA1,APOE
233	Neoplasm of the liver	C0023903	6	1290	3.65162891625e-06	0.00022106261859582545	APOA4,APOC3,APOC2,APOA1,APOE,LPL
234	Inclusion Body Myopathy, Sporadic	C0751713	2	53	3.74461996933e-06	0.000222011385199241	TOMM40,APOE
235	Hepatosplenomegaly	C0019214	2	55	4.19068663271e-06	0.00022296015180265657	GPIHBP1,LPL
236	Factor V Leiden mutation	C0584960	2	56	4.42631863606e-06	0.0002239089184060721	APOE,LPL
237	Hyperglycemia	C0020456	4	459	4.6913038334e-06	0.00022485768500948766	APOA2,APOC3,APOE,LPL
253	Abnormality of the abdominal organs	C4021764	5	842	4.82293961201e-06	0.00024003795066413665	GPIHBP1,APOC2,APOA1,APOE,LPL
254	Abnormality of the skin	C0037268	6	1376	5.60387893744e-06	0.0002409867172675522	GPIHBP1,APOC2,APOA1,APOE,APOC1,LPL
255	Vascular Calcification	C0342649	2	62	6.02634249514e-06	0.00024193548387096774	APOC1,LPL
256	Cognition Disorders	C0009241	2	62	6.02634249514e-06	0.0002428842504743833	APOE,APOC1
257	Abnormality of immune system physiology	C4023616	5	884	6.38099549266e-06	0.00024383301707779886	GPIHBP1,APOC2,APOA1,APOE,LPL
258	Major depressive disorder	C1269683	4	489	6.38364510652e-06	0.00024478178368121445	APOA4,TOMM40,APOA1,APOE
268	Hepatoblastoma	C0206624	3	220	6.72263688772e-06	0.00025426944971537003	APOC3,APOA1,APOE
269	Acromegaly	C0001206	2	70	8.69791599201e-06	0.00025521821631878557	APOE,LPL
284	Acute myocardial infarction	C0155626	3	237	9.01888755633e-06	0.000269449715370019	APOA1,APOE,LPL
285	Uremia	C0041948	2	72	9.46980181527e-06	0.0002703984819734345	APOA1,APOE
286	Abnormality of the biliary system	C0940767	3	243	9.95313644991e-06	0.0002713472485768501	GPIHBP1,APOA1,LPL
287	Obesity	C0028754	7	2181	1.01993531703e-05	0.0002722960151802656	APOA2,APOA4,APOC3,APOA1,APOE,APOC1,LPL
288	Complications of Diabetes Mellitus	C0342257	2	75	1.0710514513e-05	0.0002732447817836812	APOE,LPL
289	Postoperative Complications	C0032787	2	75	1.0710514513e-05	0.00027419354838709674	APOE,LPL
290	Abnormality of the vasculature of the eye	C4024752	3	248	1.07847459015e-05	0.00027514231499051233	GPIHBP1,APOC2,LPL
299	Non-Hodgkin lymphoma	C0024305	4	556	1.18954471084e-05	0.0002836812144212524	APOA2,APOA4,APOE,LPL
300	Sciatic Neuropathy	C0149940	2	78	1.20540453051e-05	0.0002846299810246679	APOA1,APOE
301	Senile plaques	C0333463	3	259	1.27938329697e-05	0.0002855787476280835	APOA1,APOE,LPL
302	Coronary artery stenosis	C0242231	2	81	1.35044888405e-05	0.00028652751423149903	APOE,LPL
303	Stable angina	C0340288	2	82	1.40123584175e-05	0.0002874762808349146	APOA1,APOE
316	Infarction, Middle Cerebral Artery	C0740392	2	83	1.45327684113e-05	0.0002998102466793169	APOE,LPL
317	Membranous nephropathy, susceptibility to	C0017665	2	84	1.50656978808e-05	0.0003007590132827325	APOA1,APOE
318	Liver Diseases	C0023895	4	586	1.53319020078e-05	0.00030170777988614803	APOC3,APOA1,APOE,LPL
319	Abnormality of metabolism/homeostasis	C4021768	6	1607	1.55777232634e-05	0.0003026565464895636	GPIHBP1,APOC3,APOC2,APOA1,APOE,LPL
320	Abnormality of the retina	C0035300	4	599	1.70427230628e-05	0.0003036053130929791	GPIHBP1,APOC2,APOE,LPL
321	Abnormality of the coronary arteries	C0158623	2	88	1.7326357611e-05	0.0003045540796963947	APOE,LPL
334	Lipid accumulation in hepatocytes	C1837257	2	90	1.85359784817e-05	0.00031688804554079697	GPIHBP1,APOE
335	Storage in hepatocytes	C0337174	2	90	1.85359784817e-05	0.0003178368121442125	GPIHBP1,APOE
336	Diabetic Nephropathies	C0011881	4	616	1.95016777084e-05	0.0003187855787476281	APOC3,APOE,APOC1,LPL
337	Kidney Failure, Chronic	C0022661	4	616	1.95016777084e-05	0.0003197343453510437	APOC3,APOA1,APOE,LPL
338	Skin nodule	C0037287	2	92	1.98000772772e-05	0.0003206831119544592	APOE,LPL
344	Ischaemic cerebral infarction	C0007785	3	297	2.18989583217e-05	0.00032637571157495256	APOA1,APOE,LPL
345	Abnormal QRS complex	C0205161	5	1098	2.20007426143e-05	0.00032732447817836814	GPIHBP1,APOC2,APOA1,APOE,LPL
346	Peripheral Arterial Diseases	C1704436	2	96	2.24960217865e-05	0.0003282732447817837	APOE,LPL
347	Diabetes mellitus type 1	C0011854	5	1104	2.26913202599e-05	0.00032922201138519926	APOA4,APOC3,APOE,APOC1,LPL
348	Verotoxigenic Escherichia coli gastrointestinal tract infection	C0009450	5	1111	2.3519155458e-05	0.00033017077798861485	APOC3,APOA1,APOE,APOC1,LPL
356	Liver Cirrhosis, Alcoholic	C0023891	2	103	2.77761430645e-05	0.0003377609108159393	APOA1,APOE
357	Calcinosis	C0006663	2	103	2.77761430645e-05	0.00033870967741935485	APOE,LPL
358	Non-alcoholic Fatty Liver Disease	C0400966	3	317	2.82610854137e-05	0.0003396584440227704	APOC3,APOE,LPL
371	Frontotemporal dementia, ubiquitin-positive	C0236642	2	106	3.02679983413e-05	0.00035199240986717267	APOE,APOC1
372	Abnormality of the immune system	C4021753	5	1164	3.06169973368e-05	0.00035294117647058826	GPIHBP1,APOC2,APOA1,APOE,LPL
373	Fibrinogen Adverse Event	C1561955	2	108	3.20083297697e-05	0.0003538899430740038	APOC3,LPL
382	Chronic kidney disease	C1561643	3	342	3.80107599401e-05	0.00036242884250474385	APOA4,TOMM40,APOE
391	Gout	C0018099	2	116	3.96266733992e-05	0.0003709677419354839	APOA1,APOE
392	Stroke	C0038454	5	1229	4.15964615572e-05	0.00037191650853889943	APOA4,APOC3,APOA1,APOE,LPL
393	Thromboembolism	C0040038	2	118	4.17011196854e-05	0.000372865275142315	APOA4,LPL
394	Vascular inflammations	C0947751	2	119	4.27644314606e-05	0.0003738140417457306	APOA1,APOE
406	Focal segmental glomerulosclerosis	C0017668	2	121	4.49444431432e-05	0.00038519924098671726	APOE,LPL
407	Abnormality of skin morphology	C4023528	5	1261	4.8065545733e-05	0.00038614800759013284	GPIHBP1,APOC2,APOA1,APOE,LPL
408	Lymphadenopathy	C0497156	2	124	4.83493210088e-05	0.0003870967741935484	APOA1,APOE
413	Thrombophilia	C0398623	2	125	4.95208033779e-05	0.0003918406072106262	APOA4,APOE
422	Hereditary pancreatitis	C0238339	3	377	5.5541749551e-05	0.00040037950664136625	APOC2,APOE,LPL
423	Abnormality of the lymph nodes	C0149727	2	130	5.56583394618e-05	0.0004013282732447818	APOA1,APOE
424	Obesity, severe, 601665 (3)	C0028756	2	131	5.69426872459e-05	0.00040227703984819737	APOE,LPL
425	Pregnancy Complications	C0032962	2	132	5.82464195779e-05	0.0004032258064516129	APOE,LPL
426	Gingival Diseases	C0017563	2	132	5.82464195779e-05	0.0004041745730550285	APOE,LPL
429	Heart Diseases	C0018799	3	386	6.08713381575e-05	0.0004070208728652752	APOC3,APOE,LPL
430	Abnormalities of the peripheral arteries	C4025247	2	135	6.22748351016e-05	0.0004079696394686907	APOE,LPL
431	Liver Neoplasms, Experimental	C0023904	2	136	6.36571432983e-05	0.0004089184060721063	APOA4,APOC2
432	Disorders of Intracellular Cobalamin Metabolism	C0025517	3	394	6.59149126392e-05	0.00040986717267552184	APOA1,APOE,LPL
433	Abnormality of blood and blood-forming tissues	C0241657	5	1335	6.61721718723e-05	0.00041081593927893743	GPIHBP1,APOC2,APOA1,APOE,LPL
440	Jaundice	C0022346	2	141	7.08707441108e-05	0.0004174573055028463	GPIHBP1,LPL
441	Abnormality of the fundus	C4025804	4	807	7.09154909568e-05	0.00041840607210626184	GPIHBP1,APOC2,APOE,LPL
442	Abnormality of the posterior segment of the globe	C4025354	4	810	7.21748751447e-05	0.00041935483870967743	GPIHBP1,APOC2,APOE,LPL
443	Arterial stenosis	C0038449	2	142	7.23748824603e-05	0.00042030360531309296	APOE,LPL
444	Venous thrombosis	C0042487	2	142	7.23748824603e-05	0.00042125237191650855	APOA4,APOE
445	Amyotrophic Lateral Sclerosis	C0002736	4	812	7.30240946454e-05	0.0004222011385199241	APOA4,APOC3,APOE,LPL
451	Frontotemporal dementia	C0338451	2	148	8.18402231425e-05	0.0004278937381404175	APOE,APOC1
452	Weight Gain Adverse Event	C2911647	2	151	8.68621562772e-05	0.000428842504743833	APOE,LPL
457	Inflammation of the large intestine	C0578878	1	25	9.53662361241e-05	0.00043358633776091084	GPIHBP1
458	Dermatological manifestations of systemic disorders	C4025812	2	156	9.56729322654e-05	0.00043453510436432637	GPIHBP1,LPL
459	Retinopathy	C0035309	3	434	9.58415525482e-05	0.00043548387096774196	APOC3,APOA1,APOE
460	Chronic obstructive pulmonary disease	C0024117	4	865	9.85030967093e-05	0.00043643263757115754	APOA2,APOA4,APOE,LPL
461	C-like syndrome	C0039082	3	438	9.92988985689e-05	0.0004373814041745731	APOC2,APOE,LPL
462	 {High density lipoprotein cholesterol level QTL 7} (3)	C0392885	1	26	0.000103278414665	0.00043833017077798866	LPL
463	Tetraplegia	C0034372	1	26	0.000103278414665	0.0004392789373814042	APOE
464	Brain Hemorrhage, Traumatic	C0553692	1	26	0.000103278414665	0.0004402277039848198	APOA1
465	Aneurysm, Ruptured	C0162869	1	26	0.000103278414665	0.0004411764705882353	APOE
466	Albuminuria	C0001925	2	163	0.000108960853011	0.0004421252371916509	APOE,LPL
467	Lipoatrophy	C0023787	2	163	0.000108960853011	0.00044307400379506643	APOC3,APOE
468	Abnormality of macrophages	C4021661	1	27	0.000111502918483	0.000444022770398482	APOE
469	genetic hypertension	C0598428	1	27	0.000111502918483	0.00044497153700189754	LPL
470	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	C0237849	1	27	0.000111502918483	0.00044592030360531313	APOC1
471	Obstructive sleep apnea	C0520679	2	166	0.000115005603793	0.00044686907020872866	APOE,LPL
472	Acquired CJD	C2931859	1	28	0.000120039457803	0.0004478178368121442	APOE
473	Abnormality of purine metabolism	C4025346	1	28	0.000120039457803	0.0004487666034155598	APOE
474	Blurred vision	C0344232	1	28	0.000120039457803	0.0004497153700189753	APOA1
475	Proliferative retinopathy	C0339467	1	29	0.000128887595052	0.0004506641366223909	LPL
476	Femur Head Necrosis	C0015814	1	29	0.000128887595052	0.00045161290322580643	APOA1
477	Cholesterol gallstones	C0856727	1	29	0.000128887595052	0.000452561669829222	APOE
478	Hepatocellular carcinoma	C2239176	7	3108	0.000136149622479	0.00045351043643263755	APOA2,APOA4,APOC3,APOC2,APOA1,APOE,LPL
479	Down Syndrome	C0013080	3	476	0.000136846262231	0.00045445920303605313	APOC2,APOA1,APOE
480	Myeloproliferative disorder, chronic, with eosinophilia	C1851585	1	30	0.000138047123163	0.00045540796963946866	APOE
481	Absent hair	C0574763	1	30	0.000138047123163	0.00045635673624288425	APOE
482	Isolated somatotropin deficiency	C3714796	1	30	0.000138047123163	0.0004573055028462998	LPL
483	Abnormal eye morphology	C4022925	5	1529	0.000140742738279	0.00045825426944971537	GPIHBP1,APOC2,APOA1,APOE,LPL
484	Abnormality of the globe	C4022923	5	1529	0.000140742738279	0.00045920303605313095	GPIHBP1,APOC2,APOA1,APOE,LPL
485	Alcohol withdrawal syndrome	C0236663	1	31	0.000147517638029	0.0004601518026565465	APOE
486	Creutzfeldt-Jakob Disease, Sporadic	C1852467	1	31	0.000147517638029	0.00046110056925996207	APOE
487	Herpes zoster disease	C0019360	1	31	0.000147517638029	0.0004620493358633776	APOE
488	Hemiplegia	C0018991	1	31	0.000147517638029	0.0004629981024667932	APOE
489	Spinal cord compression	C0037926	1	31	0.000147517638029	0.0004639468690702087	APOE
490	Herpes simplex encephalitis, susceptibility to, 7	C0276226	1	31	0.000147517638029	0.0004648956356736243	APOE
491	Apathy	C0085632	1	31	0.000147517638029	0.00046584440227703984	APOE
492	Corneal opacity	C0010038	2	183	0.000153420927499	0.0004667931688804554	APOA1,APOE
493	Eclampsia	C0013537	2	183	0.000153420927499	0.00046774193548387096	APOE,LPL
494	Familial Alzheimer Disease (FAD)	C0276496	1	32	0.000157298902305	0.00046869070208728654	APOE
495	Stenosis	C0678234	1	32	0.000157298902305	0.00046963946869070213	APOE
496	Metabolic Bone Disorder	C0005944	1	32	0.000157298902305	0.00047058823529411766	APOE
497	Niemann-Pick disease, type C	C0220756	1	32	0.000157298902305	0.00047153700189753325	APOE
498	Arteriovenous hemangioma	C0334533	1	32	0.000157298902305	0.0004724857685009488	APOE
499	Chronic Kidney Insufficiency	C0403447	2	186	0.000160963498464	0.00047343453510436436	APOA4,APOE
500	Abnormality of cardiovascular system electrophysiology	C0243050	5	1568	0.000161746004997	0.0004743833017077799	GPIHBP1,APOC2,APOA1,APOE,LPL
501	Abdominal pain	C0000737	2	187	0.000163530328548	0.0004753320683111955	GPIHBP1,LPL
502	Dominant hereditary optic atrophy	C0338508	1	33	0.000167390596578	0.000476280834914611	TOMM40
503	Normal pressure hydrocephalus	C0020258	1	33	0.000167390596578	0.0004772296015180266	APOE
504	Abnormality of cells of the monocyte/macrophage lineage	C4023025	1	33	0.000167390596578	0.00047817836812144213	APOE
505	Carotid Artery Diseases	C0007273	2	190	0.000171390363119	0.0004791271347248577	APOE,LPL
506	Crohn Disease	C0010346	4	979	0.000176356693944	0.0004800759013282733	APOA4,APOA1,APOE,LPL
507	Cycloid psychosis	C0349204	2	192	0.00017676470035	0.00048102466793168883	TOMM40,APOE
508	Aortic aneurysm without mention of rupture NOS	C0340629	1	34	0.0001777923162	0.0004819734345351044	APOE
509	Parkinson disease, late-onset	C3160718	1	34	0.0001777923162	0.0004829222011385199	APOE
510	Inflammatory Bowel Diseases	C0021390	4	985	0.000181475657276	0.0004838709677419355	APOA4,APOA1,APOE,LPL
511	Brain Diseases	C0006111	2	194	0.000182247613904	0.000484819734345351	APOA1,APOE
512	Macular Degeneration	C0024437	2	194	0.000182247613904	0.0004857685009487666	APOE,APOC1
513	Endemic Cretinism	C0342200	1	35	0.000188503825816	0.00048671726755218213	APOE
514	heavy drinking	C0687132	1	35	0.000188503825816	0.0004876660341555977	APOE
515	Cocaine delirium	C0011206	1	35	0.000188503825816	0.0004886148007590133	APOE
516	Endometriosis of ovary	C0156344	1	35	0.000188503825816	0.0004895635673624289	APOA2
517	Spots on skin	C0848332	2	198	0.00019354291644	0.0004905123339658445	APOA1,APOE
518	Drug-Induced Liver Injury	C0860207	2	198	0.00019354291644	0.00049146110056926	APOA1,APOE
519	Complete trisomy 18 syndrome	C0152096	1	36	0.000199524690491	0.0004924098671726755	APOA1
520	Abnormality of the axillary hair	C4022287	1	36	0.000199524690491	0.0004933586337760911	APOE
521	Death, Sudden, Cardiac	C0011065	2	203	0.000208290075716	0.0004943074003795067	APOA1,APOE
522	Corneal Diseases	C0010034	1	37	0.000210854792632	0.0004952561669829222	APOE
523	Psychiatric symptom	C0233401	1	37	0.000210854792632	0.0004962049335863378	APOE
524	Spastic	C0443306	1	37	0.000210854792632	0.0004971537001897534	APOE
525	Peripheral artery occlusive disease	C1306889	1	37	0.000210854792632	0.000498102466793169	APOE
526	Sclerosis	C0036429	1	37	0.000210854792632	0.0004990512333965844	APOE
527	Hypertension	C0020538	5	1647	0.000211984586677	0.0005	APOC3,APOA1,APOE,APOC1,LPL
528	Transient ischemic attack	C0007787	2	205	0.00021438743847	0.0005009487666034156	APOE,LPL
529	Lymphoma, AIDS-Related	C0085090	1	38	0.000222493583919	0.0005018975332068312	APOE
530	Chronic myelopathy	C0037928	1	38	0.000222493583919	0.0005028462998102467	APOE
531	Herpesviridae Infections	C0019372	1	38	0.000222493583919	0.0005037950664136622	APOE
532	Acute disease of cardiovascular system	C0001314	1	38	0.000222493583919	0.0005047438330170778	APOE
533	Abnormality of the integument	C4025761	5	1665	0.000225010865852	0.0005056925996204934	GPIHBP1,APOC2,APOA1,APOE,LPL
534	Depressive Disorder	C0011581	3	543	0.000226771370175	0.0005066413662239089	APOA4,TOMM40,APOE
535	Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis	C0033687	2	209	0.000226927675768	0.0005075901328273245	APOA1,APOE
536	Pancreatitis, Alcoholic	C0376670	1	39	0.00023444094465	0.0005085388994307401	APOE
537	Abnormality of nucleobase metabolism	C4023643	1	39	0.00023444094465	0.0005094876660341557	APOE
538	Wet Macular Degeneration	C0205381	1	39	0.00023444094465	0.0005104364326375711	APOE
539	Aphasia	C0003537	1	39	0.00023444094465	0.0005113851992409867	APOE
540	Neurobehavioral Manifestations	C0525041	1	39	0.00023444094465	0.0005123339658444023	APOE
541	Cerebroretinal microangiopathy with calcifications and cysts 1	C0155765	1	39	0.00023444094465	0.0005132827324478179	APOE
542	Abnormality of the digestive system	C0266015	5	1679	0.000235578168044	0.0005142314990512335	GPIHBP1,APOC2,APOA1,APOE,LPL
543	{Unipolar depression, susceptibility to}, 608516 (3)	C0011570	3	555	0.000246522060639	0.000515180265654649	APOA4,TOMM40,APOE
544	Exfoliation Syndrome	C0206368	1	40	0.000246696356873	0.0005161290322580645	APOE
545	Alcoholic Steatohepatitis	C2718067	1	40	0.000246696356873	0.0005170777988614801	APOE
546	CADASIL	C0751587	1	41	0.000259259787018	0.0005180265654648957	APOE
547	Delusions	C0011253	1	41	0.000259259787018	0.0005189753320683112	APOE
548	Gastrointestinal inflammation	C1535950	1	41	0.000259259787018	0.0005199240986717268	GPIHBP1
549	Confusion	C0009676	1	41	0.000259259787018	0.0005208728652751424	APOE
550	Hypoplastic left heart syndrome	C0152101	1	42	0.000272130604832	0.0005218216318785579	APOE
551	Cellulitis	C0007642	1	43	0.000285308744364	0.0005227703984819735	APOE
552	Nephrotic Syndrome, Minimal Change	C1704321	1	44	0.000298793723785	0.000523719165085389	APOE
553	Primary Carcinoma	C1335475	1	44	0.000298793723785	0.0005246679316888046	APOC1
554	Myelomeningocele	C0025312	1	44	0.000298793723785	0.0005256166982922202	APOE
555	AIDS Dementia Complex	C0001849	1	44	0.000298793723785	0.0005265654648956358	APOE
556	Disease Progression	C0242656	2	233	0.000312242721512	0.0005275142314990512	APOA4,APOE
557	Age-related cataract	C0036646	1	45	0.000312585274259	0.0005284629981024668	APOE
558	Bone necrosis	C0029445	1	45	0.000312585274259	0.0005294117647058824	APOA1
559	Hippocampal sclerosis	C1504404	1	45	0.000312585274259	0.000530360531309298	APOE
560	Drug usage	C0242510	1	45	0.000312585274259	0.0005313092979127135	APOE
561	Blepharitis	C0005741	1	45	0.000312585274259	0.0005322580645161291	APOE
562	Autosomal recessive polycystic kidney disease	C0085548	1	45	0.000312585274259	0.0005332068311195447	APOE
563	Stage 5 chronic kidney disease	C2316810	2	234	0.000316186501064	0.0005341555977229602	APOA1,APOE
564	Pediatric Obesity	C2362324	1	46	0.000326683170725	0.0005351043643263758	APOE
565	Heart valve disease	C0018824	1	46	0.000326683170725	0.0005360531309297912	APOE
566	Weight Loss Adverse Event	C2911645	1	46	0.000326683170725	0.0005370018975332068	APOC3
567	Focal segmental glomerulosclerosis 1	C0333497	1	46	0.000326683170725	0.0005379506641366224	APOE
568	Dermal atrophy	C0151514	2	237	0.000328210793882	0.000538899430740038	APOE,APOC1
569	Sepsis	C0243026	3	602	0.00033600672316	0.0005398481973434534	APOA1,APOE,APOC1
570	Trisomy 12	C0432408	1	47	0.000341087007202	0.000540796963946869	LPL
571	Learning Disorders	C0023186	1	47	0.000341087007202	0.0005417457305502846	APOE
572	Bradykinesia	C0233565	1	47	0.000341087007202	0.0005426944971537002	APOE
573	Drusen	C1260959	1	47	0.000341087007202	0.0005436432637571158	APOE
574	Varicella zoster	C0740380	1	47	0.000341087007202	0.0005445920303605312	APOE
575	Sickle Cell Trait	C0037054	1	47	0.000341087007202	0.0005455407969639468	APOE
576	Virilism	C0042755	1	48	0.000355796437584	0.0005464895635673624	APOE
577	Pulmonary infiltrates	C0235896	1	48	0.000355796437584	0.000547438330170778	APOE
578	Bile duct cancer resectable	C0740277	1	48	0.000355796437584	0.0005483870967741935	APOE
579	Abnormality of secondary sexual hair	C4024171	1	48	0.000355796437584	0.0005493358633776091	APOE
580	Multiple Sclerosis	C0026769	4	1140	0.000358331602971	0.0005502846299810247	APOC2,APOA1,APOE,APOC1
581	Acute Cerebrovascular Accidents	C0751956	1	49	0.0003708112049	0.0005512333965844402	APOE
582	Lung Neoplasms	C0024121	4	1155	0.000380663124742	0.0005521821631878557	APOC3,APOA1,APOE,LPL
583	Iron deficiency anemia	C0162316	1	50	0.000386130990193	0.0005531309297912713	APOE
584	Vascular lesions	C1402315	1	50	0.000386130990193	0.0005540796963946869	APOE
585	Fragile X tremor/ataxia syndrome	C1839780	1	51	0.00040175550701	0.0005550284629981025	APOE
586	Aural atresia, congenital	C1842937	1	51	0.00040175550701	0.0005559772296015181	APOE
587	Pseudoxanthoma elasticum	C0473583	1	51	0.00040175550701	0.0005569259962049335	APOE
588	Silicosis	C0037116	1	51	0.00040175550701	0.0005578747628083491	APOA1
589	Nephrosis	C0027720	1	51	0.00040175550701	0.0005588235294117647	APOA1
590	Guillain-Barre syndrome, familial	C0018378	1	52	0.000417684296358	0.0005597722960151803	APOE
591	Prenatal Exposure Delayed Effects	C0033054	1	52	0.000417684296358	0.0005607210626185958	APOE
592	Drug Resistant Epilepsy	C1096063	1	53	0.000433917269073	0.0005616698292220114	APOE
593	Ischemia	C0022116	3	647	0.000441659635371	0.000562618595825427	APOC3,APOE,LPL
594	Endometrial Hyperplasia	C0014173	1	54	0.000450453941	0.0005635673624288425	APOE
595	Nausea	C0027497	1	54	0.000450453941	0.0005645161290322581	LPL
596	Low Tension Glaucoma	C0152136	1	54	0.000450453941	0.0005654648956356736	APOE
597	Neuropathy ataxia retinitis pigmentosa syndrome	C0442874	2	265	0.000454932055698	0.0005664136622390892	APOA2,APOE
598	Abnormality of the eye	C0015393	5	1900	0.000461740552553	0.0005673624288425048	GPIHBP1,APOC2,APOA1,APOE,LPL
599	Diabetic Retinopathy	C0011884	2	270	0.000480426326647	0.0005683111954459204	APOA1,APOE
600	Necrosis	C0027540	1	56	0.00048443731585	0.0005692599620493358	LPL
601	Hypoalbuminemia	C0239981	1	56	0.00048443731585	0.0005702087286527514	LPL
602	Memory Disorders	C0025261	1	56	0.00048443731585	0.000571157495256167	APOE
603	Diabetic Cardiomyopathies	C0853897	1	56	0.00048443731585	0.0005721062618595826	APOA1
604	Anemia, Sickle Cell	C0002895	2	271	0.000485633146779	0.0005730550284629981	APOA1,APOE
605	Biliary tract neoplasm	C0005426	1	57	0.00050188342042	0.0005740037950664137	APOE
606	Optic neuropathy	C0029132	1	57	0.00050188342042	0.0005749525616698292	APOE
607	Ketoacidosis	C0022638	1	57	0.00050188342042	0.0005759013282732448	APOE
608	Chronic neutrophilia	C3665444	1	57	0.00050188342042	0.0005768500948766604	APOA1
609	Tropical Spastic Paraparesis	C0030481	1	58	0.000519631902073	0.0005777988614800759	APOA2
610	Inflammatory abnormality of the skin	C3875321	2	278	0.000523100921707	0.0005787476280834915	GPIHBP1,APOA1
611	Increased intracranial pressure	C0151740	1	59	0.000537682707993	0.0005796963946869071	APOE
612	Intrahepatic cholestasis	C0008372	1	60	0.000556035323142	0.0005806451612903226	APOE
613	Wilson disease	C0019202	1	60	0.000556035323142	0.0005815939278937381	APOE
614	CNS symptom	C1457887	1	60	0.000556035323142	0.0005825426944971537	APOE
615	Optic neuritis	C0029134	1	60	0.000556035323142	0.0005834914611005693	APOE
616	Abnormality of skin physiology	C4023527	2	286	0.000568142030976	0.0005844402277039849	GPIHBP1,APOA1
617	Menopause present (finding)	C0150312	1	61	0.000574689573903	0.0005853889943074005	APOE
618	Cooley's anemia	C0002875	1	61	0.000574689573903	0.0005863377609108159	APOE
619	Memory Loss	C0002622	1	61	0.000574689573903	0.0005872865275142315	APOE
